BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28984704)

  • 1. The promises of immunotherapy in gliomas.
    Mildenberger I; Bunse L; Ochs K; Platten M
    Curr Opin Neurol; 2017 Dec; 30(6):650-658. PubMed ID: 28984704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
    Pollack IF; Okada H; Chambers WH
    Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic approaches for glioma.
    Okada H; Kohanbash G; Zhu X; Kastenhuber ER; Hoji A; Ueda R; Fujita M
    Crit Rev Immunol; 2009; 29(1):1-42. PubMed ID: 19348609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma immunology and immunotherapy.
    Parney IF; Hao C; Petruk KC
    Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells.
    De Vleeschouwer S; Van Gool SW; Van Calenbergh F
    Childs Nerv Syst; 2005 Jan; 21(1):7-18. PubMed ID: 15452731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts in glioma immunotherapy.
    Platten M; Bunse L; Wick W; Bunse T
    Cancer Immunol Immunother; 2016 Oct; 65(10):1269-75. PubMed ID: 27460064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in cellular immunotherapy for brain/CNS tumors.
    Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
    Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concepts for Immunotherapies in Gliomas.
    Platten M; Reardon DA
    Semin Neurol; 2018 Feb; 38(1):62-72. PubMed ID: 29548053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies.
    Wang JY; Bettegowda C
    J Neurooncol; 2015 Jul; 123(3):373-83. PubMed ID: 25697584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Immunotherapeutic Approaches for Malignant Gliomas.
    Han MH; Kim CH
    Brain Tumor Res Treat; 2022 Jan; 10(1):1-11. PubMed ID: 35118842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of current immunotherapeutic strategies for glioma.
    Calinescu AA; Kamran N; Baker G; Mineharu Y; Lowenstein PR; Castro MG
    Immunotherapy; 2015; 7(10):1073-104. PubMed ID: 26598957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic strategies for malignant glioma.
    Fenstermaker RA; Ciesielski MJ
    Cancer Control; 2004; 11(3):181-91. PubMed ID: 15153842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies.
    Khan-Farooqi HR; Prins RM; Liau LM
    Neurol Res; 2005 Oct; 27(7):692-702. PubMed ID: 16197806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in immunotherapy for human glioma.
    Carpentier AF; Meng Y
    Curr Opin Oncol; 2006 Nov; 18(6):631-6. PubMed ID: 16988586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.
    Ehtesham M; Black KL; Yu JS
    Cancer Control; 2004; 11(3):192-207. PubMed ID: 15153843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy against gliomas].
    Sahm K; Weiss T
    Nervenarzt; 2024 Feb; 95(2):111-116. PubMed ID: 38169045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.